Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivanex in Relapsed/Refractory CLL
NCT00083473Phase 2Terminated
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pivaloyloxymethyl butyrate in chronic lymphocytic leukemia (CLL), sponsored by Titan Pharmaceuticals, Inc.. Started May 2004; status: terminated.
02
Drugs
pivaloyloxymethyl butyrate
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00083473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083473.